Axsome Therapeutics, Inc.
Use of reboxetine to treat narcolepsy
Last updated:
Abstract:
Described herein are methods of treating narcolepsy with cataplexy, comprising administering reboxetine to a human being in need thereof. Reboxetine may also be used in the manufacture of a medicament for the treatment of narcolepsy with cataplexy. Also disclosed herein are kits comprising a pharmaceutical composition comprising reboxetine and instructions to use the pharmaceutical composition to treat narcolepsy with cataplexy in a human being.
Status:
Grant
Type:
Utility
Filling date:
11 Jan 2020
Issue date:
7 Jun 2022